Page last updated: 2024-08-21

alpha-aminopyridine and Impetigo Contagiosa

alpha-aminopyridine has been researched along with Impetigo Contagiosa in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (70.59)24.3611
2020's5 (29.41)2.80

Authors

AuthorsStudies
Albareda López, N; Grimalt, R; Masramon, X; Torrelo, A; Zsolt, I1
Eudaley, S1
Andriessen, A; Benjamin, LT; Claro, C; Eichenfield, LF; Esposito, SM; Keller, L; Kircik, L; Kwong, PC; McCuaig, C; Schachner, LA1
Andriessen, A; Hebert, AA; Hohl, D; Kircik, LH; Kwong, P; Lynde, CW; Oza, V; Schachner, LA; Torrelo, A1
Fortina, AB; Galli, L; Novelli, A; Ruggiero, G; Stefani, S1
Mishra, AK; Sahu, JK1
Canton, R; Chouinard, L; Tarragó, C1
Arañó, A; D'Aniello, F; Esquirol, LP; Lachamp, L; Tarragó, C; Zsolt, I1
Canton, R; García-Castillo, M; Gargallo-Viola, D; López, Y; Morrissey, I; Tato, M; Vila, J; Zsolt, I1
Albareda, N; Alonso, FG; Hebert, AA; Rosen, T; Rosenberg, N; Roth, S; Zsolt, I1
Bell, E; Eiland, LS; Wren, C1
Albareda, N; Grimalt, R; Hebert, AA; Masramon, X; Rosen, T; Rosenberg, N; Torrelo, A; Zsolt, I1
Cantón, R; García-Castillo, M; Hebert, AA; López, Y; Tato, M; Torrelo, A; Vila, J1
Andriessen, A; Bhatia, N; Grada, A; Patele, D; Schachner, L1
Cepero, AL; Gropper, S; Kruger, D; Santos, B1
Albareda, N; Chelius, K; Gani, M; García-Alonso, F; Gropper, S; Kruger, D; Mitha, I; Vahed, Y1

Reviews

8 review(s) available for alpha-aminopyridine and Impetigo Contagiosa

ArticleYear
Ozenoxacin (Xepi) for the Treatment of Impetigo.
    American family physician, 2020, 06-15, Volume: 101, Issue:12

    Topics: Administration, Topical; Aminopyridines; Anti-Bacterial Agents; Child; Child, Preschool; Humans; Impetigo; Infant; Quinolones

2020
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Journal of drugs in dermatology : JDD, 2021, 02-01, Volume: 20, Issue:2

    Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Bridged Bicyclo Compounds, Heterocyclic; Critical Pathways; Delphi Technique; Diterpenes; Drug Resistance, Bacterial; Evidence-Based Medicine; Fusidic Acid; Humans; Impetigo; Microbial Sensitivity Tests; Mupirocin; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Streptococcus pyogenes; Systematic Reviews as Topic

2021
Treatment of Impetigo and Antimicrobial Resistance.
    Journal of drugs in dermatology : JDD, 2021, Apr-01, Volume: 20, Issue:4

    Topics: Administration, Cutaneous; Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Drug Prescriptions; Drug Resistance, Bacterial; Humans; Impetigo; Microbial Sensitivity Tests; Practice Guidelines as Topic; Quinolones; Staphylococcus aureus; Treatment Outcome

2021
Pediatric impetigo: an expert panel opinion about its main controversies.
    Journal of chemotherapy (Florence, Italy), 2022, Volume: 34, Issue:5

    Topics: Aminopyridines; Anti-Bacterial Agents; Cellulitis; Child; Humans; Impetigo; Quinolones

2022
Ozenoxacin: A Novel Drug Discovery for the Treatment of Impetigo.
    Current drug discovery technologies, 2019, Volume: 16, Issue:3

    Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Drug Discovery; Drug Interactions; Humans; Impetigo; Quinolones

2019
Ozenoxacin: A Novel Topical Quinolone for Impetigo.
    The Annals of pharmacotherapy, 2018, Volume: 52, Issue:12

    Topics: Administration, Topical; Aminopyridines; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Female; Humans; Impetigo; Male; Methicillin-Resistant Staphylococcus aureus; Quinolones; Staphylococcus aureus; Treatment Outcome

2018
Ozenoxacin: a review of preclinical and clinical efficacy.
    Expert review of anti-infective therapy, 2019, Volume: 17, Issue:3

    Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Humans; Impetigo; Quinolones; Staphylococcus aureus; Treatment Outcome

2019
Topical Ozenoxacin Cream 1% for Impetigo: A Review
    Journal of drugs in dermatology : JDD, 2019, Jul-01, Volume: 18, Issue:7

    Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Clinical Decision-Making; Drug Resistance, Bacterial; Humans; Impetigo; Mutation; Patient Selection; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Treatment Outcome

2019

Trials

5 trial(s) available for alpha-aminopyridine and Impetigo Contagiosa

ArticleYear
Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.
    Dermatology (Basel, Switzerland), 2020, Volume: 236, Issue:3

    Topics: Administration, Topical; Adolescent; Aminopyridines; Anti-Bacterial Agents; Child; Humans; Impetigo; Quinolones; Skin Cream; Treatment Outcome

2020
Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
    JAMA dermatology, 2018, 07-01, Volume: 154, Issue:7

    Topics: Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Drug Resistance, Bacterial; Female; Humans; Impetigo; Infant; Male; Quinolones; Skin Cream; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Young Adult

2018
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials.
    Journal of drugs in dermatology : JDD, 2018, Oct-01, Volume: 17, Issue:10

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aminopyridines; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Europe; Female; Humans; Impetigo; Infant; Male; Middle Aged; Quinolones; Randomized Controlled Trials as Topic; Russia; Severity of Illness Index; South Africa; Treatment Outcome; United States; Young Adult

2018
Systemic bioavailability and safety of twice-daily topical ozenoxacin 1% cream in adults and children with impetigo.
    Future microbiology, 2014, Volume: 9, Issue:8 Suppl

    Topics: Administration, Topical; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Humans; Impetigo; Male; Middle Aged; Pruritus; Quinolones; Young Adult

2014
Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial.
    Future microbiology, 2014, Volume: 9, Issue:9

    Topics: Adolescent; Aminopyridines; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Child; Child, Preschool; Diterpenes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Impetigo; Male; Ointments; Quinolones

2014

Other Studies

4 other study(ies) available for alpha-aminopyridine and Impetigo Contagiosa

ArticleYear
A review of the antibacterial activity of ozenoxacin.
    Future microbiology, 2018, 05-01, Volume: 13

    Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Dogs; Humans; Impetigo; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes

2018
Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus.
    Future microbiology, 2018, 05-01, Volume: 13

    Topics: Administration, Topical; Aminopyridines; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Humans; Impetigo; Mice; Mupirocin; Ointments; Quinolones; Skin Cream; Staphylococcus aureus; Treatment Outcome; Wound Infection

2018
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.
    Future microbiology, 2018, 05-01, Volume: 13

    Topics: Aminopyridines; Anti-Bacterial Agents; Humans; Impetigo; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Staphylococcaceae; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes

2018
Ozenoxacin 1% cream (Xepi) for impetigo.
    The Medical letter on drugs and therapeutics, 2019, Apr-22, Volume: 61, Issue:1570

    Topics: Administration, Cutaneous; Aminopyridines; Anti-Bacterial Agents; Humans; Impetigo; Quinolones; Skin Cream

2019